Variablea | IBK | LZ/W | Significanceb | Effect sizeb |
---|---|---|---|---|
Participants, n | 100 | 83 | ||
Age, years | 66 [IQR: 53—71] 19—84 | 70 [IQR: 54—74] 23—82 | ns (p = 0.36) | r = 0.093 |
Sex | female: 64% (64) male: 36% (36) | female: 66% (55) male: 34% (28) | ns (p = 0.94) | V = 0.024 |
Anemia | 19% (19) | 17% (14) | ns (p = 0.94) | V = 0.028 |
Renal insufficiency | 35% (35) | 18% (15) | p = 0.043 | V = 0.19 |
Percardial effusion | 16% (16) | 3.6% (3) | p = 0.04 | V = 0.2 |
WHO class | I/II: 39% (39) III/IV: 61% (61) | I/II: 53% (44) III/IV: 47% (39) | ns (p = 0.17) | V = 0.14 |
SMWD, m | 320 [IQR: 200—400] 50—610 | 350 [IQR: 270—440] 50—620 | ns (p = 0.11) | r = 0.15 |
mPAP, mmHg | 40 [IQR: 30—50] 26—120 | 39 [IQR: 31—49] 18—67 | ns (p = 0.91) | r = 0.024 |
PVR, Wood | 10 [IQR: 6.7—17] 3.3—43 | 5 [IQR: 3.5—7.8] 1.4—20 | p < 0.001 | r = 0.54 |
5-year mortality | 21% (21) | 13% (11) | ns (p = 0.38) | V = 0.1 |
OS, months | 70 [IQR: 46—110] 2—230 | 63 [IQR: 32—110] 11—170 | ns (p = 0.51) |